Research Update

We are so thrilled to announce our newest class of Gabrielle’s Angel Foundation grantees! These 10 researchers are working on some of the most innovative blood cancer treatments in the nation and we are proud to support them. We’ve committed $2.95M in funding to these projects and a few others this year:

1. Wendy Jia Men Huang – University of California, San Diego – Long non-coding RNAs in T-cell lymphoma
2. Daniel Bachovchin – Memorial Sloan Kettering Cancer Center – Small Molecule Pyroptosis Inducers as Therapeutic Agents for AML
3. Marzenna Blonksa – University of Miami – Biological Consequences and Therapeutic Implications of Beta-arrestin2 loss in aggressive Lymphomas
4. Aaron Ring- Yale School of Medicine – Hacking cytokine pathways for precision cancer immunotherapy
5. Panagiotis Ntziachristos – Northwestern University – Post-translational regulation of splicing as a pro-oncogenic mechanism in high-risk T cell leukemia
6. Cigall Kadoch – Boston Children’s Hospital – Targeting Mammalian SWI/SNF (BAF) Chromatin Remodeling Complexes in Leukemia and Lymphoma
7. Courtney Hodges – Baylor College of Medicine Revealing novel SMARCA4-related dependencies in mixed-lineage leukemia
8. David  Dominguez-Sola – Mount Sinai – MYC-dependent replication stress as a pathogenic driver and therapeutic target in aggressive B cell lymphomas
9. Sara Buhrlage – Dana-Farber Cancer Institute – Targeting ‘undruggable’ initiating events in AML
10. Luke Gilbert – University of California, San Francisco – Applying synthetic lethality to eradicate high risk NF1 – deficient B – cell acute lymphoblastic leukemia.